MPS Pharmaa Ratios

MPS Pharmaa Ltd Ratios

The MPS Pharmaa Ltd Ratios page provides a complete fundamental analysis of MPS Pharmaa Ltd using key valuation, profitability, and financial strength metrics. Investors tracking MPS Pharmaa Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

MPS Pharmaa Ltd (NSE: , BSE: 531686) is currently trading at ₹1.81, with a market capitalization of ₹3.46Cr. As a major player in the Health technology sector and Pharmaceuticals: major industry, MPS Pharmaa Ltd remains a key stock for fundamental analysis using MPS Pharmaa Ltd Ratios.

MPS Pharmaa Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The MPS Pharmaa Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in MPS Pharmaa Ltd Ratios.

Historically, the MPS Pharmaa Ltd P/E ratio has shown strong fluctuations:

The decline in MPS Pharmaa Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The MPS Pharmaa Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

MPS Pharmaa Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The MPS Pharmaa Ltd P/S ratio currently stands at 0, an important part of MPS Pharmaa Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining MPS Pharmaa Ltd P/S ratio indicates cautious market sentiment.

MPS Pharmaa Ltd Price to Cash Flow Ratio (P/CF)

The MPS Pharmaa Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical MPS Pharmaa Ltd Price to Cash Flow Ratio:

The declining MPS Pharmaa Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

MPS Pharmaa Ltd Enterprise Value Ratios

Enterprise Value (EV)

The MPS Pharmaa Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

MPS Pharmaa Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The MPS Pharmaa Ltd EV/EBITDA ratio is currently 0, a key metric in MPS Pharmaa Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable MPS Pharmaa Ltd EV/EBITDA indicates balanced valuation.

MPS Pharmaa Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The MPS Pharmaa Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

MPS Pharmaa Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The MPS Pharmaa Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

MPS Pharmaa Ltd Ratios Analysis Summary

The MPS Pharmaa Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether MPS Pharmaa Ltd stock is undervalued, fairly valued, or overvalued.

Tracking MPS Pharmaa Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.